Related Experiment Video
Updated: Jul 5, 2026
10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Survival and Histopathological Study of Animals Bearing Ehrlich Tumor Treated With a Rhodium(II) Amidate
B P Espósito1, S B Zyngier, R Najjar
1University of São Paulo Institute of Chemistry Av. Prof. Lineu Prestes, 748 - r. 1265 São Paulo 055508-900 Brazil.
Metal-Based Drugs
|May 14, 2008
Abstract:
The survival of 90% of a tumor-bearing population treated with the complex Rh(2) (CF(3)CONH)(4) was examined and the pharmacological parameter Surv(90) determined. Histopathological alterations raised for this drug in several tissues were studied in Balb-c mice. A Surv(90) dose of 3.8x 10(-5) mol/kg was found.
